Child-Parent Familial Hypercholesterolemia Screening
Recruiting · NCT04529967 · Observational (researchers observe without assigning treatment) · Lead sponsor: Children's Hospital of Fudan University
View the official record on ClinicalTrials.gov →Interventions studied
no interventions
What this trial is about
Child-parent screening for familial hypercholesterolemia has been proposed to identify children and their parent who are carrier of mutations and with high risk for inherited premature coronary artery disease. The investigators assessed the efficacy and feasibility of such screening in primary care practice. key scientific questions: 1. The 95th and 99th percentile of finger blood TC in children of 2 years old. 2. Mutations that contribute to high TC status ( serum TC \>99th percentiles) compared with international FH48 panel for FH genetic screening.
Who can take part
Age range
1 Year to 3 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Receive routine child care
- aged 1 - 3 years old ( date of investigate minus date of birth)
Exclusion criteria
- It is up to the researcher to decide whether it is suitable to participate in this research
Where it is running
6 locations listed.
- Anhui Provincial Children's Hospital - Hefei, Anhui, China
- Qidong Women and Children Hospital - Qidong, Jiangsu, China
- Weili Yan - Shanghai, Shanghai Municipality, China
- Shanxi Provincial Children's Hospital - Taiyuan, Shanxi, China
- Chongqin Medical University Affiliated Children's Hospital - Chongqing, Sichuan, China
- Urumqi Children's Hospital - Ürümqi, Xinjiang, China